Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001070698-12-000077
Filing Date
2012-11-14
Accepted
2012-11-13 21:52:20
Documents
13
Period of Report
2012-08-31

Document Format Files

Seq Description Document Type Size
1 RAPTOR PHARMACEUTICAL CORP FORM 10-K_8-31-2012 raptor10k083112.htm 10-K 2641235
2 LIST OF SUBSIDIARIES rptp_exb211.htm EX-21.1 4184
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM rptp_exb231.htm EX-23.1 2711
4 CERTIFICATION OF CEO rptp_exb311.htm EX-31.1 6369
5 CERTIFICATION OF CFO rptp_exb312.htm EX-31.2 6261
6 CERTIFICATION OF CEO AND CFO rptp_exb321.htm EX-32.1 6581
7 chart.jpg GRAPHIC 42355
  Complete submission text file 0001070698-12-000077.txt   14242354

Data Files

Seq Description Document Type Size
8 rptp-20120831.xml EX-101.INS 1912299
9 rptp-20120831.xsd EX-101.SCH 107345
10 rptp-20120831_cal.xml EX-101.CAL 88423
11 rptp-20120831_def.xml EX-101.DEF 385248
12 rptp-20120831_lab.xml EX-101.LAB 1275244
13 rptp-20120831_pre.xml EX-101.PRE 614611
Mailing Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949
Business Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949 415-382-1390
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

EIN.: 860883978 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-25571 | Film No.: 121200736
SIC: 2834 Pharmaceutical Preparations